AMLo are delighted to announce the appointment of Dr David Swan PhD to its growing Executive Team.
David has a strong academic research background. He completed his PhD in Immunology at Newcastle University in 2011, and then carried out post-doctoral work at the University until 2019. This included leading part of a clinical study to find cellular biomarkers that would predict flare in rheumatoid arthritis patients.
More recently, David has held successive Development Scientist roles in small local biotech companies. He gained experience in product development across the development timeline: from the scientific concept stage through to the validation stage, carrying out experiments that had been stress-tested with key external stakeholders. David joins AMLo as IVD Product Development Manager and will take responsibility for development of our four IVD product lines.
